Clinical trial
Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients
NCT00444275 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00444275 |
|---|---|
| Title | Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients |
| Official title | A Randomized, Open, Parallel-group Study to Evaluate the Efficacy of Three Different Patient Management Strategies During a 12 Weeks Maintenance Phase Following an Initial 4-weeks Acute Treatment Phase in Subjects With Symptoms Thought to be GERD Related |
| Acronym | MAESTRO |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | GERD |
| Intervention type | Drug |
| Interventions | esomeprazole (Nexium®), Xolaam® |
| Enrollment | 3,029 |
| Start date | Mar 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 7, 2007 |
| Last update posted | Dec 11, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: